October 1 update. Our PDGM and ICD-10 tools now use the FY2027 code set: 190 codes added, 30 deleted, and no existing code changed clinical group.

See what changed

ICD-10 · PDGM grouping

R87 Abnormal findings in specimens from female genital organs

All 31 codes in the R87 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.

ICD-10-CM FY2027 · CMS grouper v07.2.26

Codes in family

31

Can lead a claim

0

Cannot lead a claim

31

What CMS assigns to R87

None of the 31 codes is assigned a clinical group. None of the 31 is assigned a comorbidity subgroup. None can lead a claim.

Every code in R87

Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.

CodeDescriptionPrimary positionClinical groupComorbidity subgroup
R87.0Abnormal level of enzymes in specimens from female genital organsCMS: Abn lev enzymes in specimens from female genital organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.1Abnormal level of hormones in specimens from female genital organsCMS: Abn lev hormones in specimens from female genital organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.2Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organsCMS: Abn lev drug/meds/biol subst in specmn from fem gntl organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organsCMS: Abn lev substnc nonmed source in specmn from fem gntl organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.4Abnormal immunological findings in specimens from female genital organsCMS: Abn immunolog findings in specmn from female genital organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.5Abnormal microbiological findings in specimens from female genital organsCMS: Abn microbiolog find in specmn from female genital organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.6 Abnormal cytological findings in specimens from female genital organs
R87.61 Abnormal cytological findings in specimens from cervix uteri
R87.610Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)CMS: Atyp squam cell of undet signfc cyto smr crvx (ASC-US)Cannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.611Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)CMS: Atyp squam cell not excl hi grd intrepith lesn cyto smr crvxCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.612Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)CMS: Low grade intrepith lesion cyto smr crvx (LGSIL)Cannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.613High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)CMS: High grade intrepith lesion cyto smr crvx (HGSIL)Cannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.614Cytologic evidence of malignancy on smear of cervixCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.615Unsatisfactory cytologic smear of cervixCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.616Satisfactory cervical smear but lacking transformation zoneCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.618Other abnormal cytological findings on specimens from cervix uteriCMS: Oth abnormal cytolog findings on specimens from cervix uteriCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.619Unspecified abnormal cytological findings in specimens from cervix uteriCMS: Unsp abnormal cytolog findings in specmn from cervix uteriCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.62 Abnormal cytological findings in specimens from vagina
R87.620Atypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US)CMS: Atyp squam cell of undet signfc cyto smr vagn (ASC-US)Cannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.621Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)CMS: Atyp squam cell not excl hi grd intrepith lesn cyto smr vagnCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.622Low grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL)CMS: Low grade intrepith lesion cyto smr vagn (LGSIL)Cannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.623High grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL)CMS: High grade intrepith lesion cyto smr vagn (HGSIL)Cannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.624Cytologic evidence of malignancy on smear of vaginaCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.625Unsatisfactory cytologic smear of vaginaCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.628Other abnormal cytological findings on specimens from vaginaCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.629Unspecified abnormal cytological findings in specimens from vaginaCMS: Unsp abnormal cytological findings in specimens from vaginaCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.69Abnormal cytological findings in specimens from other female genital organsCMS: Abn cytolog find in specmn from oth female genital organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.7Abnormal histological findings in specimens from female genital organsCMS: Abn histolog findings in specmn from female genital organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.8 Other abnormal findings in specimens from female genital organs
R87.81 High risk human papillomavirus (HPV) DNA test positive from female genital organs
R87.810Cervical high risk human papillomavirus (HPV) DNA test positiveCMS: Cervical high risk HPV DNA test positiveCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.811Vaginal high risk human papillomavirus (HPV) DNA test positiveCMS: Vaginal high risk HPV DNA test positiveCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.82 Low risk human papillomavirus (HPV) DNA test positive from female genital organs
R87.820Cervical low risk human papillomavirus (HPV) DNA test positiveCMS: Cervical low risk HPV DNA test positiveCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.821Vaginal low risk human papillomavirus (HPV) DNA test positiveCMS: Vaginal low risk HPV DNA test positiveCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.89Other abnormal findings in specimens from female genital organsCMS: Oth abnormal findings in specmn from female genital organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
R87.9Unspecified abnormal finding in specimens from female genital organsCMS: Unsp abnormal finding in specmn from female genital organsCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone

Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue